Sindhura Ravindra

Sindhura Ravindra practices at Camden Clark Medical Center in Parkersburg, West Virginia, part of West Virginia University Health System.

Sindhura Ravindra's NPI, 1093197618, was assigned on June 19, 2015. Sindhura Ravindra holds Illinois license 125066240.

Sindhura Ravindra's primary practice is Camden Clark Medical Center, at 800 Garfield Ave, Parkersburg, WV 26101 in Wood County. The practice phone is (304) 424-2111.

Sindhura Ravindra's primary practice is Camden Clark Medical Center in Parkersburg, West Virginia, part of West Virginia University Health System. Sindhura Ravindra is also affiliated with WVU Medicine Wetzel County Hospital. The medical group on file is Camden Clark Medical Center. Dmand AI also links Sindhura Ravindra to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sindhura Ravindra practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Sindhura Ravindra's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sindhura Ravindra is licensed in Illinois.

CMS data shows 720 Medicare services from Sindhura Ravindra across 7 procedure codes in 2024, for 247 Medicare patients. Medicare paid $36,299 for them.

CMS counts 247 Medicare patients who saw Sindhura Ravindra in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sindhura Ravindra's median patient age at 61, with 64% women.

In 2024, Sindhura Ravindra wrote 2,741 Medicare Part D claims for 367 patients. 40% of them were for generic drugs. CMS names the drug for 2,475 of them, across 40 drugs with 11 or more claims each, at $1,202,641 in total drug cost. In 2023, CMS named 1,864 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Sindhura Ravindra for performance year 2024, reported through an alternative payment model (APM). Sindhura Ravindra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sindhura Ravindra as offering telehealth.

CMS Open Payments shows 14 general payments to Sindhura Ravindra from 10 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 97% of the total. Eli Lilly and Company paid the most, $140.